Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 11;25(24):13301.
doi: 10.3390/ijms252413301.

Coumarins and Hesperetin Inhibit Human Respiratory Syncytial Virus Infection

Affiliations

Coumarins and Hesperetin Inhibit Human Respiratory Syncytial Virus Infection

Jéssica Maróstica de Sá et al. Int J Mol Sci. .

Abstract

Respiratory syncytial virus (RSV) is one of the most prevalent viruses that causes severe acute lower respiratory tract infections (ALRTIs) in the elderly and young children. There is no specific drug to treat RSV, only a broad-spectrum antiviral, ribavirin, which is only used in critical cases. Our research group is investigating antiviral agents of natural origin, such as coumarins and flavonoids, that may help reduce or prevent RSV infection. The cytotoxic concentrations of coumarins and hesperetin were tested on A549 and HEp-2 cells and used in inhibition tests in which 80% of the cells were viable. The anti-RSV action of the molecules was analyzed in A549 and HEp-2 cells and in HBE cell cultures infected with RSV-luc or rgRSV. We also encapsulated the compounds using β-cyclodextrin to improve the permeability and solubility of the molecules. Esculetin and 4-methyl inhibited rgRSV effectively on A549 and HEp-2 cells after 24 hpi, and when they were encapsulated, coumarin, esculetin, and hesperetin presented inhibition against rgRSV in HBE culture. The coumarins inhibit RSV replication in cell culture and even manage to overcome the mucus barriers of the HBE cultures, and β-cyclodextrin was essential for some of the coumarins to enter the cell and therefore to reach their targets.

Keywords: A549 cells; HBE culture; HEp-2 cells; RSV; coumarins; hesperetin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Cytotoxicity assay by MTT of natural coumarins on HEp-2 cells following 48 h of incubation with the test compounds coumarin, esculetin, esculin, 4-methyl esculetin, and umbelliferone. The hexagon with dotted red line represents Staurosporine (1 mM), negative control, in which 50% of the cells remain viable.
Figure 2
Figure 2
(A) Fluorescence microscopy images taken using the green fluorescent protein (GFP) filter at 24, 48, and 72 h to demonstrate the spread of virus infection in treated cells compared with the untreated control or the DMSO-treated control. Treatment of rgRSV infection of HEp-2 cells with coumarin, esculetin, esculin, 4-methyl esculetin, and umbelliferone (before and after infection). HEp-2 cells were cultured overnight and inoculated with rgRSV. (B) The black line represents RSV infection in the presence of the coumarins, the red line is the DMSO solvent control, and the blue line represents the infection without compounds.
Figure 3
Figure 3
Inhibition assay with RSV-luc on A549 cells at 48 h for coumarins and 24 h for hesperetin at. The black lines and circles represent RSV infection in the presence of the compounds (coumarin, esculetin, esculin, 4-methyl esculetin, umbelliferone and hesperetin), red lines and squares represent RSV infection in the presence of the DMSO, and blue lines and triangle represents RSV infection in the absence of a compound.
Figure 4
Figure 4
Inhibition plot of RSV-luc infection of A549 in the presence of compounds esculetin, 4-methyl esculetin, and hesperetin, at 24 and 48 h.
Figure 5
Figure 5
Inhibition assay on A549 cell with RSV-luc for acetylated and prenylated umbelliferone at 24 h. The black lines and circles represent RSV infection in the presence of the compounds (coumarin, esculetin, esculin, 4-methyl esculetin, umbelliferone and hesperetin), red lines and squares represent RSV infection in the presence of the DMSO (solvent), and blue lines and triangles represent RSV infection without DMSO or compounds.
Figure 6
Figure 6
Inhibition assay of the encapsulated compounds on differentiated HBE cultures inoculated with RSV-luc, at 48 h. The black line and circles represents RSV infection in the presence of the encapsulated compounds (coumarin, esculetin, esculin, 4-methyl esculetin, umbelliferone and hesperetin), the red line and squares shows the RSV infection in the presence only of β-cyclodextrin, and the blue line and triangle represents the RSV infection with no additions.
Figure 7
Figure 7
RSV replication and spread in different cell lines and in primary HBE cultures in the presence of coumarins, hesperetin and modified umbelliferones. GFP-expressing RSV replication and spread in (A) HEp-2 cells as measured by virus yield in focus forming units ± standard deviation (SD). Replication and spread of RSV expressing luciferase, measured in relative light units (RLU) ± SD in A549 cells (B,D), and (C) HBE cultures. Statistical significance Significant differences are indicated as follows: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 and ns is non- significant.

Similar articles

References

    1. Zhu G., Xu D., Zhang Y., Wang T., Zhang L., Gu W., Shen M. Epidemiological characteristics of four common respiratory viral infections in children. Virol. J. 2021;18:10. doi: 10.1186/s12985-020-01475-y. - DOI - PMC - PubMed
    1. Messina A., Germano C., Avellis V., Tavella E., Dodaro V., Massaro A., Vitale R., Masturzo B., Manzoni P. New strategies for the prevention of respiratory syncytial virus (RSV) Early Hum. Dev. 2022;174:105666. doi: 10.1016/j.earlhumdev.2022.105666. - DOI - PubMed
    1. Calışkan M., Bochkov Y.A., Kreiner-Møller E., Bønnelykke K., Stein M.M., Du G., Bisgaard H., Jackson D.J., Gern J.E., Lemanske R.F., Jr., et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N. Engl. J. Med. 2013;11:1398–1407. doi: 10.1056/NEJMoa1211592. - DOI - PMC - PubMed
    1. Sigurs N., Aljassim F., Kjellman B., Robinson P.D., Sigurbergsson F., Bjarnason R., Gustafsson P.M. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010;12:1045–1052. doi: 10.1136/thx.2009.121582. - DOI - PubMed
    1. Priante E., Cavicchiolo M.E., Baraldi E. RSV infection and respiratory sequelae. Minerva Pediatr. 2018;70:623–633. doi: 10.23736/S0026-4946.18.05327-6. - DOI - PubMed

MeSH terms

LinkOut - more resources